Notice: This company has been marked as potentially delisted and may not be actively trading. Neurotrope (NTRP) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesShort InterestTrends Get the Latest News and Ratings for NTRP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Neurotrope and its competitors. Enter your email to sign up for newsletter Sign Up NTRP Analyst Ratings Over TimeTypeCurrent Forecast2/24/24 to 2/23/251 Month Ago1/25/24 to 1/24/253 Months Ago11/26/23 to 11/25/241 Year Ago2/24/23 to 2/24/24Strong Buy0 Strong Buy rating(s) N/A N/A N/A Buy0 Buy rating(s) N/A N/A N/A Hold1 Hold rating(s) N/A N/A N/A Sell0 Sell rating(s) N/A N/A N/A Consensus Price Target$5.00N/AN/AN/AForecasted Upside16.55% UpsideN/AN/AN/AConsensus RatingHoldN/AN/AN/A NTRP Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History NTRP Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Neurotrope Stock vs. The CompetitionTypeNeurotropeConsumer Discretionary CompaniesS&P 500Consensus Rating Score 2.00 2.60 2.53Consensus RatingHoldModerate BuyModerate BuyPredicted Upside16.55% Upside2,010.51% Upside14.33% UpsideNews Sentiment RatingNeutral NewsSee Recent NTRP NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails2/11/2025HC Wainwright2 of 5 starsScott BuckSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetNeutral ➝ Neutral$2.50 ➝ $5.00-0.99%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 01:30 AM ET. NTRP Forecast - Frequently Asked Questions What is Neurotrope's forecast for 2025? According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Neurotrope is $5.00, with a high forecast of $5.00 and a low forecast of $5.00. Should I buy or sell Neurotrope stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Neurotrope in the last twelve months. There is currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NTRP shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NTRP, but not buy additional shares or sell existing shares. Does Neurotrope's stock price have much upside? According to analysts, Neurotrope's stock has a predicted upside of 16.55% based on their 12-month stock forecasts. What analysts cover Neurotrope? Neurotrope has been rated by research analysts at HC Wainwright in the past 90 days. Do Wall Street analysts like Neurotrope more than its competitors? Analysts like Neurotrope less than other "consumer discretionary" companies. The consensus rating for Neurotrope is Hold while the average consensus rating for "consumer discretionary" companies is Moderate Buy. Learn more on how NTRP compares to other companies. Stock Forecasts and Research Tools Related Companies MOND Stock Forecast BKNG Stock Forecast EXPE Stock Forecast XPO Stock Forecast MMYT Stock Forecast GATX Stock Forecast GXO Stock Forecast VRRM Stock Forecast GBTG Stock Forecast RXO Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:NTRP) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurotrope, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurotrope With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
